Mesoblast Limited (ASX:MSB) FDA Grants Orphan Drug Designation For Use Of Proprietary Stem Cells In Bone Marrow Transpla

  Melbourne, Australia, Sept 17, 2008 - (ABN Newswire) - Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today announced that the United States Food and Drug Administration (FDA) has granted an orphan drug designation for the use of the patented adult stem cell technology in patients undergoing bone marrow transplantation.The FDA awarded Mesoblast's US-based sister company, Angioblast Systems Inc.  

Sydney

  [ Change ]
 
Today

Min: 12°
Max: 19°
Possible afternoon shower.
Tomorrow

Min: 12°
Max: 19°
Possible afternoon shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online